Ultragenyx Pharmaceutical
RARE
#5177
Rank
HK$13.35 B
Marketcap
HK$131.03
Share price
5.03%
Change (1 day)
-48.19%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: HK$13.35 Billion

As of November 2026 Ultragenyx Pharmaceutical has a market cap of HK$13.35 Billion. This makes Ultragenyx Pharmaceutical the world's 5177th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$13.35 B-47.96%
2025HK$25.66 B-17.55%
2024HK$31.12 B1.5%
2023HK$30.66 B20.85%
2022HK$25.37 B-43.22%
2021HK$44.69 B-37.05%
2020HK$70.99 B269.02%
2019HK$19.23 B11.09%
2018HK$17.31 B12.21%
2017HK$15.43 B-30.73%
2016HK$22.27 B-34.1%
2015HK$33.80 B211.04%
2014HK$10.86 B

End of Day market cap according to different sources

On Nov 16th, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

HK$12.71 Billion
by Nasdaq info icon info icon
HK$12.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
HK$6.21 B-53.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$6.42 B-51.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.69 B 167.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$88.91 B 565.82%๐Ÿ‡บ๐Ÿ‡ธ USA